Endocrine Gland Neoplasms

4

Review clinical trials related to Endocrine Gland Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital

This study examines how the American College of Surgeons Geriatric Surgery Verification Program, also called the ACS GSV Program, is implemented at the James Cancer Hospital. The program is designed to improve surgical care for adults age 65 and older by helping care teams identify and address age-related needs before, during, and after surgery. Older adults with cancer may have concerns related to physical function, memory or thinking, medications, social support, and goals of care. If these needs are not recognized, patients may be at higher risk for complications, longer hospital stays, readmission, or discharge to a facility instead of home. The ACS GSV Program includes standards for geriatric surgery leadership, goals-of-care discussions, screening for age-related vulnerabilities, care plans for identified needs, age-friendly perioperative care, and regular review of surgical outcomes. This study will evaluate how well these standards are adopted across surgical oncology services and whether implementation is associated with better outcomes, such as shorter hospital stays, fewer complications, fewer readmissions, and improved discharge outcomes. The results may help improve surgical care workflows for older adults undergoing cancer surgery.

Participants needed: 4,000
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Ohio State University Comprehensive Cancer CenterUpdated: May 29, 2026Locations: 1
Eligibility criteria

Patient records for adults aged 65 years or older [+3]

Patient records for encounters occurring only at outside institutions or non-Jam... [+3]

Status: Recruiting

Establishment of a Tumor Bank for Tissue Samples

Establishment of a tumor bank, consisting of tissue samples of tumor patients (benign and malign tumors) and healthy people as controls. The tissue samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tissue tumor bank. This tumor bank for tissue samples, together with our tumorbank for blood samples (NCT01763125) combined constitute the entity "Tumorbank".

Participants needed: 10,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Medical University of ViennaUpdated: Mar 23, 2023Locations: 3
Eligibility criteria

Male/Female [+2]

Inflammatory disease and malignant disease [+3]

Status: Recruiting

Establishment of a Tumor Bank for Blood Samples

Establishment of a tumor bank, consisting of blood samples of tumor patients and healthy people as controls. The blood samples will be collected systematically together with the corresponding clinical data. The biological samples, the clinical date together with prospective experimental date constitute the entity of the tumor bank.

Participants needed: 10,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Medical University of ViennaUpdated: Mar 23, 2023Locations: 6
Eligibility criteria

Male/Female [+3]

Inflammatory disease and malignant disease [+3]

Status: Recruiting

Spanish Series of Patients Treated With the Radionuclide Lutetium177

This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice and to learn about the profiles of patients and tumors treated and the results in each type of patient and tumor.

Participants needed: 5,000
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Sociedad Española de Medicina Nuclear e Imagen MolecularUpdated: Dec 23, 2022Locations: 20
Eligibility criteria

Written informed consent must be obtained prior to any data collection. [+2]

None